Home / Dobutamine / United States
US ATC C01CA07 · updated 2 Nov 2026
Dobutamine shortage in United States
Is there a Dobutamine shortage in United States?
Yes. As of 2 Nov 2026, 10 Dobutamine products are reported short in United States, the first since 6 Nov 2017. No return date has been given. Main reason: not stated.
Also short in France, Italy, Austria, Japan. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02) | Baxter Healthcare | 6 Nov 2017 | not given | Not stated |
| US | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02) | Baxter Healthcare | 6 Nov 2017 | not given | Not stated |
| US | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02) | Baxter Healthcare | 6 Nov 2017 | not given | Not stated |
| US | Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80) | Hainan Poly Pharm. Co., Ltd. | 6 Nov 2017 | not given | Not stated |
| US | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01) | Hospira, Inc., a Pfizer Company | 6 Nov 2017 | not given | Not stated |
| US | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02) | Hospira, Inc., a Pfizer Company | 6 Nov 2017 | not given | Not stated |
| US | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88) | Hospira, Inc., a Pfizer Company | 6 Nov 2017 | not given | Other |
| US | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (4 mg/mL) (NDC 0409-1100-10) | Hospira, Inc., a Pfizer Company | 6 Nov 2017 | not given | Not stated |
| US | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (1 mg/mL) (NDC 0409-0025-10) | Hospira, Inc., a Pfizer Company | 6 Nov 2017 | not given | Not stated |
| US | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (2 mg/mL) (NDC 0409-0151-10) | Hospira, Inc., a Pfizer Company | 6 Nov 2017 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).